Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients.
Placebo or propranolol was given randomly of two groups of 12 adults with cirrhosis who had recently held from oesophageal or gastric varices or from acute gastric erosions. During three months' follow-up 5 patients in the placebo and none in the propranolol group had recurrent gastrointestinal bleeding.
D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000517:prevention & control*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control*; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use*; D011897:Random Allocation; D012008:Recurrence; D013276:Stomach Ulcer / Q000150:complications
D010919:Placebos; D011433:Propranolol